Loading company…
Super Vision develops medical devices for ophthalmology, including products for glaucoma and eye movement disorders.
Founded in 2018 and based in Beijing, China, Super Vision develops ophthalmic medical devices. Its products address myopia, glaucoma, and pediatric ophthalmology, including an implantable glaucoma micro drainage pump and an eye muscle nerve stimulation system. In March 2026, it raised Series C funding from Beyond Ventures to advance research and clinical trials for an implantable nystagmus stimulator.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in